CAT Caterpillar | $338.65
-0.4% | 2/3/2025 | Upgraded by | Wedbush | - | Outperform | | Low | View details for Wedbush rating of Caterpillar (NYSE:CAT) on 2/3/2025 |
MGM MGM Resorts International | $36.32
+0.9% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | N/A | View details for Wedbush rating of MGM Resorts International (NYSE:MGM) on 2/13/2025 |
INFA Informatica | $19.30
+0.0% | 2/14/2025 | Downgraded by | Wedbush | - | Neutral | | N/A | View details for Wedbush rating of Informatica (NYSE:INFA) on 2/14/2025 |
SMCI Super Micro Computer | $51.61
-8.0% | 2/18/2025 | Reiterated by | Wedbush | - | Hold -> Hold | | N/A | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 2/18/2025 |
SNOW Snowflake | $170.78
-4.0% | 1/22/2025 | Target Set by | Wedbush | Analyst D. Ives | | $210.00 | High | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 1/22/2025 |
CINT CI&T | $7.42
+0.7% | 2/3/2025 | Target Set by | Wedbush | Analyst D. Ives | | $9.00 | High | View details for Wedbush rating of CI&T (NYSE:CINT) on 2/3/2025 |
TSLA Tesla | $330.53
-2.2% | 2/12/2025 | Target Set by | Wedbush | Analyst Dan Ives | | $328.50 | Medium | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 2/12/2025 |
CVNA Carvana | $216.05
-3.2% | 2/19/2025 | Target Set by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $250.00 | Medium | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/19/2025 |
AVTX Avalo Therapeutics | $8.10
-4.0% | 2/20/2025 | Upgraded by | Wedbush | Analyst R. Driscoll | Strong-Buy | | High | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 2/20/2025 |
PTGX Protagonist Therapeutics | $36.00
-7.1% | 2/21/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | Low | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 2/21/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
W Wayfair | $41.32
-1.2% | 2/21/2025 | Reiterated by | Wedbush | Analyst S. Basham | Neutral | $44.00 -> $46.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/21/2025 |
AXTI AXT | $1.34
-15.2% | 2/21/2025 | Reiterated by | Wedbush | - | Outperform | $5.50 -> $4.50 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/21/2025 |
BJRI BJ's Restaurants | $37.99
-0.2% | 2/21/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $43.00 -> $48.00 | High | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 2/21/2025 |
AVTX Avalo Therapeutics | $8.10
-4.0% | 2/21/2025 | Initiated by | Wedbush | - | Outperform | $18.00 | High | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 2/21/2025 |
TXRH Texas Roadhouse | $172.05
+1.7% | 2/21/2025 | Target Lowered by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $220.00 -> $200.00 | High | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/21/2025 |
SHAK Shake Shack | $115.55
+6.3% | 2/21/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $115.00 -> $125.00 | High | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 2/21/2025 |
JACK Jack in the Box | $36.78
-4.4% | 2/21/2025 | Downgraded by | Wedbush | Analyst N. Setyan | Outperform -> Neutral | $50.00 -> $40.00 | Medium | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 2/21/2025 |
BMRN BioMarin Pharmaceutical | $69.00
+1.1% | 2/20/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $94.00 | Low | View details for Wedbush rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/20/2025 |
HR Healthcare Realty Trust | $16.85
+2.2% | 2/20/2025 | Reiterated by | Wedbush | Analyst R. Anderson | Outperform | $16.00 | Low | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 2/20/2025 |
SWTX SpringWorks Therapeutics | $56.56
-2.9% | 2/20/2025 | Reiterated by | Wedbush | - | Outperform | $81.00 | High | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/20/2025 |
IMAX IMAX | $26.24
+0.8% | 2/20/2025 | Reiterated by | Wedbush | - | Outperform | $32.00 | High | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/20/2025 |
NVDA NVIDIA | $130.28
-3.1% | 2/20/2025 | Reiterated by | Wedbush | - | Outperform | $175.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/20/2025 |
WING Wingstop | $236.51
+1.1% | 2/20/2025 | Target Lowered by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $390.00 -> $355.00 | High | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/20/2025 |
CAKE Cheesecake Factory | $55.07
+0.8% | 2/20/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $59.00 -> $61.00 | High | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 2/20/2025 |
WOOF Petco Health and Wellness | $2.90
-0.3% | 2/19/2025 | Reiterated by | Wedbush | - | Outperform | $6.00 | Medium | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 2/19/2025 |
TPH Tri Pointe Homes | $31.49
+2.3% | 2/18/2025 | Reiterated by | Wedbush | - | Neutral | $44.00 -> $38.00 | High | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 2/18/2025 |
CMRX Chimerix | $4.76
-7.6% | 2/18/2025 | Reiterated by | Wedbush | - | Outperform | $6.00 -> $7.00 | High | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 2/18/2025 |
RH RH | $346.93
+2.0% | 2/18/2025 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $500.00 | High | View details for Wedbush rating of RH (NYSE:RH) on 2/18/2025 |
CNK Cinemark | $27.12
-1.2% | 2/18/2025 | Reiterated by | Wedbush | Analyst A. Reese | Neutral | $32.00 | Medium | View details for Wedbush rating of Cinemark (NYSE:CNK) on 2/18/2025 |
TOL Toll Brothers | $110.58
-0.8% | 2/14/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 2/14/2025 |
DOC Healthpeak Properties | $19.83
+0.4% | 2/14/2025 | Target Lowered by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $27.00 -> $24.00 | Low | View details for Wedbush rating of Healthpeak Properties (NYSE:DOC) on 2/14/2025 |
VTR Ventas | $67.81
+2.6% | 2/14/2025 | Target Raised by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $69.00 -> $78.00 | Medium | View details for Wedbush rating of Ventas (NYSE:VTR) on 2/14/2025 |
WEN Wendy's | $15.94
+4.8% | 2/14/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $15.50 -> $16.00 | High | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/14/2025 |
WELL Welltower | $150.74
+1.5% | 2/14/2025 | Upgraded by | Wedbush | Analyst Richard Anderson | Neutral -> Outperform | $145.00 -> $167.00 | Low | View details for Wedbush rating of Welltower (NYSE:WELL) on 2/14/2025 |
FND Floor & Decor | $97.61
+3.5% | 2/14/2025 | Downgraded by | Wedbush | Analyst Seth Basham | Outperform -> Neutral | $110.00 -> $100.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/14/2025 |
BPMC Blueprint Medicines | $92.48
+0.2% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform | $124.00 -> $128.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 2/13/2025 |
U Unity Software | $27.53
-2.9% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform | $27.00 | High | View details for Wedbush rating of Unity Software (NYSE:U) on 2/13/2025 |
DBD Diebold Nixdorf | $43.28
-2.6% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform | $60.00 | Medium | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 2/13/2025 |
BROS Dutch Bros | $75.13
-1.3% | 2/13/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $65.00 -> $100.00 | High | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 2/13/2025 |
DENN Denny's | $5.42
+1.9% | 2/13/2025 | Target Lowered by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $10.00 -> $8.50 | High | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/13/2025 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
ANAB AnaptysBio | $17.20
-7.5% | 2/12/2025 | Reiterated by | Wedbush | - | Outperform | $40.00 | High | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 2/12/2025 |
LYFT Lyft | $12.72
-2.5% | 2/12/2025 | Target Lowered by | Wedbush | Analyst S. Devitt | Neutral -> Neutral | $18.00 -> $16.00 | High | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 2/12/2025 |
DASH DoorDash | $195.87
-2.0% | 2/12/2025 | Target Raised by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $160.00 -> $210.00 | Medium | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 2/12/2025 |
GFS GlobalFoundries | $41.52
-2.1% | 2/12/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $60.00 -> $60.00 | Medium | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 2/12/2025 |
SMCI Super Micro Computer | $51.61
-8.0% | 2/12/2025 | Target Raised by | Wedbush | Analyst Matt Bryson | Neutral -> Neutral | $24.00 -> $40.00 | Low | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 2/12/2025 |
DDI DoubleDown Interactive | $9.79
-1.7% | 2/12/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $21.00 -> $21.00 | High | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 2/12/2025 |
IMAX IMAX | $26.24
+0.8% | 2/12/2025 | Reiterated by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $32.00 -> $32.00 | Medium | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/12/2025 |
Z Zillow Group | $75.15
+0.3% | 2/12/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Outperform | $100.00 -> $100.00 | High | View details for Wedbush rating of Zillow Group (NASDAQ:Z) on 2/12/2025 |
SAGE Sage Therapeutics | $7.49
+2.5% | 2/12/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $6.00 -> $6.00 | Low | View details for Wedbush rating of Sage Therapeutics (NASDAQ:SAGE) on 2/12/2025 |
BCAX Bicara Therapeutics | $12.98
-0.2% | 2/12/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $31.00 -> $31.00 | Low | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 2/12/2025 |
ARVN Arvinas | $16.75
-5.7% | 2/11/2025 | Reiterated by | Wedbush | - | Outperform | $57.00 | Medium | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 2/11/2025 |
CXW CoreCivic | $18.26
+1.3% | 2/11/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $30.00 | High | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 2/11/2025 |
VYGR Voyager Therapeutics | $4.10
-2.8% | 2/11/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $11.00 -> $9.00 | High | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 2/11/2025 |
SHOP Shopify | $115.45
-0.1% | 2/11/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $125.00 -> $125.00 | Medium | View details for Wedbush rating of Shopify (NYSE:SHOP) on 2/11/2025 |
TSEM Tower Semiconductor | $44.19
-2.1% | 2/11/2025 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform | $60.00 | Low | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 2/11/2025 |
MCD McDonald's | $307.34
+0.8% | 2/11/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $320.00 -> $330.00 | Low | View details for Wedbush rating of McDonald’s (NYSE:MCD) on 2/11/2025 |
WDC Western Digital | $49.02
-4.9% | 2/10/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $95.00 -> $95.00 | Low | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 2/10/2025 |
SWTX SpringWorks Therapeutics | $56.56
-2.9% | 2/10/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $77.00 -> $77.00 | Medium | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/10/2025 |
ROKU Roku | $91.24
+2.7% | 2/10/2025 | Reiterated by | Wedbush | - | Outperform | $100.00 -> $100.00 | Medium | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/10/2025 |
MNKD MannKind | $5.70
-1.0% | 2/10/2025 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $11.00 | High | View details for Wedbush rating of MannKind (NASDAQ:MNKD) on 2/10/2025 |
EXPE Expedia Group | $199.97
+1.6% | 2/7/2025 | Reiterated by | Wedbush | - | Neutral | $180.00 -> $215.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 2/7/2025 |
AXTI AXT | $1.34
-15.2% | 2/7/2025 | Reiterated by | Wedbush | - | Outperform | $5.50 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/7/2025 |
RBLX Roblox | $61.09
-2.3% | 2/7/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $83.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 2/7/2025 |
SAFE Safehold | $17.40
+3.4% | 2/7/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Neutral -> Neutral | $20.00 -> $19.00 | Low | View details for Wedbush rating of Safehold (NYSE:SAFE) on 2/7/2025 |
NBIX Neurocrine Biosciences | $119.11
-1.3% | 2/7/2025 | Target Lowered by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $157.00 -> $147.00 | High | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/7/2025 |
PINS Pinterest | $36.99
-2.0% | 2/7/2025 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $38.00 -> $46.00 | Medium | View details for Wedbush rating of Pinterest (NYSE:PINS) on 2/7/2025 |
TTWO Take-Two Interactive Software | $212.02
+0.2% | 2/7/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $215.00 -> $215.00 | High | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 2/7/2025 |
SWI SolarWinds | $18.30
-0.1% | 2/7/2025 | Downgraded by | Wedbush | Analyst D. Ives | Outperform -> Neutral | $20.00 -> $18.50 | High | View details for Wedbush rating of SolarWinds (NYSE:SWI) on 2/7/2025 |
AMZN Amazon.com | $212.71
-1.8% | 2/7/2025 | Reiterated by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $280.00 -> $280.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 2/7/2025 |
DENN Denny's | $5.42
+1.9% | 2/7/2025 | Upgraded by | Wedbush | Analyst Nick Setyan | Neutral -> Outperform | $6.00 -> $10.00 | Medium | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/7/2025 |
BCAX Bicara Therapeutics | $12.98
-0.2% | 2/5/2025 | Upgraded by | Wedbush | Analyst D. Nierengarten | Strong-Buy | | High | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 2/5/2025 |
KURA Kura Oncology | $7.88
-4.5% | 2/6/2025 | Target Raised by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $34.00 -> $36.00 | High | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 2/6/2025 |
CVNA Carvana | $216.05
-3.2% | 2/6/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $250.00 -> $250.00 | Medium | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/6/2025 |
ORLY O'Reilly Automotive | $1,314.91
+0.9% | 2/6/2025 | Target Raised by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $1,200.00 -> $1,350.00 | Low | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/6/2025 |
BCAX Bicara Therapeutics | $12.98
-0.2% | 2/6/2025 | Initiated by | Wedbush | Analyst David Nierengarten | Outperform | $31.00 | High | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 2/6/2025 |
AMD Advanced Micro Devices | $108.11
-2.5% | 2/5/2025 | Reiterated by | Wedbush | - | Outperform | $150.00 | Medium | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 2/5/2025 |
BYON Beyond | $6.91
-9.6% | 2/5/2025 | Reiterated by | Wedbush | - | Outperform | $15.00 | High | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/5/2025 |
CRSR Corsair Gaming | $11.61
-1.8% | 2/5/2025 | Reiterated by | Wedbush | - | Outperform | $10.00 -> $12.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 2/5/2025 |
CMG Chipotle Mexican Grill | $51.15
-0.7% | 2/5/2025 | Target Lowered by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $69.00 -> $64.00 | High | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 2/5/2025 |
MTH Meritage Homes | $72.26
-2.1% | 2/4/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $103.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 2/4/2025 |
ABNB Airbnb | $144.82
-0.9% | 2/4/2025 | Reiterated by | Wedbush | - | Outperform | $155.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 2/4/2025 |
CINT CI&T | $7.42
+0.7% | 2/3/2025 | Upgraded by | Wedbush | Analyst D. Ives | Strong-Buy | | Medium | View details for Wedbush rating of CI&T (NYSE:CINT) on 2/3/2025 |
PAY Paymentus | $28.19
+2.8% | 2/3/2025 | Initiated by | Wedbush | Analyst D. Ives | Outperform | | Low | View details for Wedbush rating of Paymentus (NYSE:PAY) on 2/3/2025 |
HURN Huron Consulting Group | $125.30
+1.3% | 2/3/2025 | Initiated by | Wedbush | Analyst D. Ives | Outperform | | Low | View details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 2/3/2025 |
IBM International Business Machines | $262.12
+0.2% | 2/3/2025 | Initiated by | Wedbush | Analyst D. Ives | Outperform | | High | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 2/3/2025 |
ANAB AnaptysBio | $17.20
-7.5% | 2/3/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $40.00 -> $40.00 | High | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 2/3/2025 |
CVCO Cavco Industries | $518.32
-0.5% | 2/3/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $480.00 -> $550.00 | Medium | View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 2/3/2025 |
TSEM Tower Semiconductor | $44.19
-2.1% | 2/3/2025 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform | $60.00 | Medium | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 2/3/2025 |
BXP Boston Properties | $68.92
+0.1% | 1/30/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Hold -> Strong Sell | | Medium | View details for Wedbush rating of Boston Properties (NYSE:BXP) on 1/30/2025 |
PHM PulteGroup | $101.64
-1.4% | 1/31/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $135.00 | Low | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 1/31/2025 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
DT Dynatrace | $59.02
-1.4% | 1/31/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform | $67.00 | Low | View details for Wedbush rating of Dynatrace (NYSE:DT) on 1/31/2025 |
BZH Beazer Homes USA | $22.77
-2.4% | 1/31/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $45.00 | Low | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 1/31/2025 |
GPRO GoPro | $0.79
+1.1% | 1/31/2025 | Reiterated by | Wedbush | - | Neutral | $1.50 -> $1.50 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 1/31/2025 |
GOOG Alphabet | $181.19
-0.2% | 1/30/2025 | Reiterated by | Wedbush | - | Outperform | $220.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOG) on 1/30/2025 |
CCS Century Communities | $70.71
-0.6% | 1/30/2025 | Reiterated by | Wedbush | - | Neutral | $96.00 -> $93.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 1/30/2025 |
WDC Western Digital | $49.02
-4.9% | 1/30/2025 | Reiterated by | Wedbush | - | Outperform | $95.00 | Medium | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 1/30/2025 |
META Meta Platforms | $668.13
-2.3% | 1/30/2025 | Reiterated by | Wedbush | - | Outperform | $700.00 -> $770.00 | High | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 1/30/2025 |
EAT Brinker International | $153.04
+5.6% | 1/30/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $140.00 -> $185.00 | Low | View details for Wedbush rating of Brinker International (NYSE:EAT) on 1/30/2025 |
ARE Alexandria Real Estate Equities | $97.16
+1.7% | 1/29/2025 | Reiterated by | Wedbush | - | Neutral | $104.00 | Medium | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 1/29/2025 |
SRRK Scholar Rock | $37.16
-1.4% | 1/29/2025 | Reiterated by | Wedbush | - | Outperform | $47.00 | High | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/29/2025 |
SBUX Starbucks | $113.19
+1.3% | 1/29/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $95.00 -> $100.00 | High | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 1/29/2025 |
PINS Pinterest | $36.99
-2.0% | 1/28/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $38.00 | Medium | View details for Wedbush rating of Pinterest (NYSE:PINS) on 1/28/2025 |
RH RH | $346.93
+2.0% | 1/27/2025 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $500.00 | Medium | View details for Wedbush rating of RH (NYSE:RH) on 1/27/2025 |
AMZN Amazon.com | $212.71
-1.8% | 1/27/2025 | Reiterated by | Wedbush | - | Outperform | $260.00 -> $280.00 | High | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 1/27/2025 |
ZNTL Zentalis Pharmaceuticals | $2.22
-4.3% | 1/24/2025 | Reiterated by | Wedbush | Analyst R. Driscoll | Neutral | $4.00 | Low | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 1/24/2025 |
CATX Perspective Therapeutics | $2.73
-1.1% | 1/24/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $11.00 | Low | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 1/24/2025 |
OKLO Oklo | $34.13
-12.0% | 1/24/2025 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $26.00 -> $45.00 | Low | View details for Wedbush rating of Oklo (NYSE:OKLO) on 1/24/2025 |
AAPL Apple | $247.10
+0.6% | 1/23/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $325.00 -> $325.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 1/23/2025 |
EA Electronic Arts | $134.05
+2.4% | 1/23/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $173.00 -> $173.00 | High | View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 1/23/2025 |
PLTR Palantir Technologies | $90.68
-10.5% | 1/23/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $75.00 -> $90.00 | Medium | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 1/23/2025 |
SNOW Snowflake | $170.78
-4.0% | 1/21/2025 | Upgraded by | Wedbush | Analyst D. Ives | Hold -> Strong-Buy | | Low | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 1/21/2025 |
LOGI Logitech International | $103.38
-0.6% | 1/22/2025 | Reiterated by | Wedbush | - | Neutral | $88.00 | High | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 1/22/2025 |
STX Seagate Technology | $100.08
-0.8% | 1/22/2025 | Reiterated by | Wedbush | - | Outperform | $150.00 | Low | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 1/22/2025 |
NFLX Netflix | $988.47
-1.5% | 1/22/2025 | Reiterated by | Wedbush | - | Outperform | $950.00 -> $1,150.00 | High | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 1/22/2025 |
META Meta Platforms | $668.13
-2.3% | 1/22/2025 | Reiterated by | Wedbush | Analyst Meta Marshall | Outperform -> Outperform | $680.00 -> $700.00 | Medium | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 1/22/2025 |
TSLA Tesla | $330.53
-2.2% | 1/22/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $515.00 -> $550.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/22/2025 |
CMG Chipotle Mexican Grill | $51.15
-0.7% | 1/22/2025 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $69.00 -> $69.00 | Medium | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 1/22/2025 |
IRON Disc Medicine | $54.64
+0.2% | 1/21/2025 | Reiterated by | Wedbush | - | Outperform | $83.00 -> $90.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 1/21/2025 |
DHI D.R. Horton | $126.43
+0.4% | 1/17/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $180.00 | Low | View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 1/17/2025 |
IMAX IMAX | $26.24
+0.8% | 1/17/2025 | Reiterated by | Wedbush | - | Outperform | $32.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 1/17/2025 |
KROS Keros Therapeutics | $10.79
-2.1% | 1/17/2025 | Downgraded by | Wedbush | Analyst Y. Zhong | Outperform -> Neutral | $47.00 -> $15.00 | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 1/17/2025 |
PZZA Papa Johns International | $48.73
+2.1% | 1/15/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $60.00 -> $60.00 | Medium | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 1/15/2025 |
SHAK Shake Shack | $115.55
+6.3% | 1/15/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $130.00 -> $130.00 | Low | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 1/15/2025 |
CATX Perspective Therapeutics | $2.73
-1.1% | 1/13/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $11.00 | High | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 1/13/2025 |
KNSA Kiniksa Pharmaceuticals | $19.63
-1.9% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $34.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 1/13/2025 |
NVCR NovoCure | $21.24
-3.8% | 1/13/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral | $29.00 | High | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 1/13/2025 |
SWTX SpringWorks Therapeutics | $56.56
-2.9% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $77.00 | High | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/13/2025 |
NUVL Nuvalent | $78.03
-1.8% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $115.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 1/13/2025 |
BEAM Beam Therapeutics | $30.79
+1.2% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $57.00 | High | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 1/13/2025 |
SYRE Spyre Therapeutics | $21.26
-0.1% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $65.00 | Medium | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 1/13/2025 |
ORIC ORIC Pharmaceuticals | $7.56
-1.6% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $20.00 | High | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/13/2025 |
IMNM Immunome | $9.35
-1.8% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $33.00 | Medium | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 1/13/2025 |
COGT Cogent Biosciences | $7.46
-6.8% | 1/13/2025 | Reiterated by | Wedbush | - | Neutral | $11.00 | High | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 1/13/2025 |
UMH UMH Properties | $18.03
+2.1% | 1/13/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Neutral -> Neutral | $20.00 -> $20.00 | Medium | View details for Wedbush rating of UMH Properties (NYSE:UMH) on 1/13/2025 |
RARE Ultragenyx Pharmaceutical | $41.84
-1.8% | 1/13/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $46.00 -> $48.00 | High | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/13/2025 |
BPMC Blueprint Medicines | $92.48
+0.2% | 1/13/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $135.00 -> $124.00 | High | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 1/13/2025 |
INZY Inozyme Pharma | $1.24
-0.8% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 1/10/2025 |
IRON Disc Medicine | $54.64
+0.2% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $83.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 1/10/2025 |
MRSN Mersana Therapeutics | $0.56
+4.4% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $7.00 -> $4.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 1/10/2025 |
ITOS iTeos Therapeutics | $7.34
-0.9% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $25.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 1/10/2025 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
NTLA Intellia Therapeutics | $11.51
-5.4% | 1/10/2025 | Reiterated by | Wedbush | - | Neutral | $14.00 -> $10.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 1/10/2025 |
YMAB Y-mAbs Therapeutics | $5.69
-0.5% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $23.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 1/10/2025 |
IGMS IGM Biosciences | $1.34
-2.9% | 1/10/2025 | Reiterated by | Wedbush | Analyst R. Driscoll | Outperform -> Neutral | $22.00 -> $3.00 | High | View details for Wedbush rating of IGM Biosciences (NASDAQ:IGMS) on 1/10/2025 |
VICI VICI Properties | $32.01
+2.3% | 1/8/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Strong-Buy -> Hold | | Medium | View details for Wedbush rating of VICI Properties (NYSE:VICI) on 1/8/2025 |
BXP Boston Properties | $68.92
+0.1% | 1/8/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Strong Sell -> Hold | | High | View details for Wedbush rating of Boston Properties (NYSE:BXP) on 1/8/2025 |
SRRK Scholar Rock | $37.16
-1.4% | 1/9/2025 | Reiterated by | Wedbush | - | Outperform | $47.00 | Low | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/9/2025 |
ROKU Roku | $91.24
+2.7% | 1/8/2025 | Reiterated by | Wedbush | - | Outperform | $100.00 | High | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 1/8/2025 |
LGIH LGI Homes | $75.99
-2.3% | 1/7/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $125.00 -> $115.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 1/7/2025 |
MTH Meritage Homes | $72.26
-2.1% | 1/7/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $205.00 -> $103.00 | Medium | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 1/7/2025 |
GETY Getty Images | $2.21
-5.4% | 1/7/2025 | Reiterated by | Wedbush | - | Outperform | $7.70 | High | View details for Wedbush rating of Getty Images (NYSE:GETY) on 1/7/2025 |
NUVB Nuvation Bio | $2.09
-5.7% | 1/6/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 1/6/2025 |
RH RH | $346.93
+2.0% | 1/6/2025 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $500.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 1/6/2025 |
GOOGL Alphabet | $179.25
-0.2% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $210.00 -> $220.00 | N/A | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 1/6/2025 |
MELI MercadoLibre | $2,223.35
-1.6% | 1/6/2025 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $2,200.00 -> $2,100.00 | N/A | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 1/6/2025 |
BKNG Booking | $5,049.08
+1.2% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5,000.00 -> $5,500.00 | N/A | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 1/6/2025 |
LYFT Lyft | $12.72
-2.5% | 1/6/2025 | Target Lowered by | Wedbush | Analyst S. Devitt | Neutral -> Neutral | $20.00 -> $18.00 | N/A | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 1/6/2025 |
TTD Trade Desk | $74.20
+3.0% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $135.00 -> $145.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 1/6/2025 |
META Meta Platforms | $668.13
-2.3% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $640.00 -> $680.00 | N/A | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 1/6/2025 |
W Wayfair | $41.32
-1.2% | 1/6/2025 | Downgraded by | Wedbush | Analyst S. Basham | Outperform -> Neutral | $45.00 -> $44.00 | N/A | View details for Wedbush rating of Wayfair (NYSE:W) on 1/6/2025 |
AMZN Amazon.com | $212.71
-1.8% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $250.00 -> $260.00 | N/A | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 1/6/2025 |
STRW Strawberry Fields REIT | $11.68
+1.9% | 1/6/2025 | Initiated by | Wedbush | Analyst R. Anderson | Outperform | $12.00 | N/A | View details for Wedbush rating of Strawberry Fields REIT (NYSEAMERICAN:STRW) on 1/6/2025 |
SHOP Shopify | $115.45
-0.1% | 1/6/2025 | Upgraded by | Wedbush | Analyst S. Devitt | Neutral -> Outperform | $115.00 -> $125.00 | N/A | View details for Wedbush rating of Shopify (NYSE:SHOP) on 1/6/2025 |
PHM PulteGroup | $101.64
-1.4% | 1/3/2025 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 1/3/2025 |
PEB Pebblebrook Hotel Trust | $11.78
-0.7% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $13.00 | N/A | View details for Wedbush rating of Pebblebrook Hotel Trust (NYSE:PEB) on 1/2/2025 |
HR Healthcare Realty Trust | $16.85
+2.2% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $18.00 -> $16.00 | N/A | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 1/2/2025 |
CTRE CareTrust REIT | $25.06
+0.5% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $34.00 -> $26.00 | N/A | View details for Wedbush rating of CareTrust REIT (NASDAQ:CTRE) on 1/2/2025 |
BXP Boston Properties | $68.92
+0.1% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $81.00 -> $70.00 | N/A | View details for Wedbush rating of Boston Properties (NYSE:BXP) on 1/2/2025 |
VICI VICI Properties | $32.01
+2.3% | 1/2/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $34.00 -> $33.00 | N/A | View details for Wedbush rating of VICI Properties (NYSE:VICI) on 1/2/2025 |
DEI Douglas Emmett | $16.02
-0.6% | 1/2/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $19.00 -> $21.00 | N/A | View details for Wedbush rating of Douglas Emmett (NYSE:DEI) on 1/2/2025 |
RCKT Rocket Pharmaceuticals | $10.05
-4.0% | 12/30/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $32.00 | N/A | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/30/2024 |
AAPL Apple | $247.10
+0.6% | 12/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $325.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/26/2024 |
TCRX TScan Therapeutics | $2.13
-1.8% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/23/2024 |
NUVB Nuvation Bio | $2.09
-5.7% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 12/23/2024 |
IKNA Ikena Oncology | $1.39
| 12/23/2024 | Reiterated by | Wedbush | - | Neutral | $2.00 | N/A | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 12/23/2024 |
SIMO Silicon Motion Technology | $56.85
-3.3% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $90.00 | N/A | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 12/23/2024 |
BZH Beazer Homes USA | $22.77
-2.4% | 12/23/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $45.00 | N/A | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 12/23/2024 |
FENC Fennec Pharmaceuticals | $6.75
+1.5% | 12/20/2024 | Reiterated by | Wedbush | - | Outperform | $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 12/20/2024 |
DRI Darden Restaurants | $194.83
+1.9% | 12/20/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $200.00 -> $220.00 | N/A | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/20/2024 |
XMTR Xometry | $31.31
-3.0% | 12/20/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $48.00 | N/A | View details for Wedbush rating of Xometry (NASDAQ:XMTR) on 12/20/2024 |
LAC Lithium Americas | C$4.10
-2.4% | 12/19/2024 | Upgraded by | Wedbush | Analyst D. Ives | Hold | | N/A | View details for Wedbush rating of Lithium Americas (TSE:LAC) on 12/19/2024 |
SNOW Snowflake | $170.78
-4.0% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 12/18/2024 |
ESTC Elastic | $104.92
-1.4% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/18/2024 |
VTR Ventas | $67.81
+2.6% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/19/2024 |
TRIP Tripadvisor | $15.02
-0.6% | 12/19/2024 | Reiterated by | Wedbush | - | Neutral | $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 12/19/2024 |
LEN Lennar | $119.79
-0.7% | 12/19/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/19/2024 |
HMST HomeStreet | $9.74
-0.6% | 12/19/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $12.00 -> $15.00 | N/A | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 12/19/2024 |
TTD Trade Desk | $74.20
+3.0% | 12/19/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/19/2024 |
INOD Innodata | $59.21
-4.4% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $48.00 | N/A | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 12/19/2024 |
LAC Lithium Americas | $2.88
-2.9% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Neutral | $5.00 | N/A | View details for Wedbush rating of Lithium Americas (NYSE:LAC) on 12/19/2024 |
OKLO Oklo | $34.13
-12.0% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $26.00 | N/A | View details for Wedbush rating of Oklo (NYSE:OKLO) on 12/19/2024 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
SWI SolarWinds | $18.30
-0.1% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $20.00 | N/A | View details for Wedbush rating of SolarWinds (NYSE:SWI) on 12/19/2024 |
OS Onestream | $24.64
-0.2% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $40.00 | N/A | View details for Wedbush rating of Onestream (NASDAQ:OS) on 12/19/2024 |
TXRH Texas Roadhouse | $172.05
+1.7% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 -> $200.00 | N/A | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/19/2024 |
MNRO Monro | $18.48
-1.2% | 12/18/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $31.00 | N/A | View details for Wedbush rating of Monro (NASDAQ:MNRO) on 12/18/2024 |
BLDR Builders FirstSource | $138.57
+0.9% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $230.00 -> $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 12/18/2024 |
CRM Salesforce | $308.27
-0.5% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $425.00 -> $425.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 12/18/2024 |
MU Micron Technology | $95.41
-3.5% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 -> $140.00 | N/A | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/17/2024 |
CSR Centerspace | $64.48
+0.6% | 12/17/2024 | Initiated by | Wedbush | Analyst R. Anderson | Neutral | $72.00 | N/A | View details for Wedbush rating of Centerspace (NYSE:CSR) on 12/17/2024 |
GEO The GEO Group | $25.65
+1.2% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 12/17/2024 |
IDYA IDEAYA Biosciences | $21.31
-2.5% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
NBIX Neurocrine Biosciences | $119.11
-1.3% | 12/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $148.00 -> $148.00 | N/A | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
SOUN SoundHound AI | $9.43
-8.5% | 12/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $10.00 -> $22.00 | N/A | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 12/16/2024 |
HOV Hovnanian Enterprises | $106.88
-12.1% | 12/16/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $155.00 | N/A | View details for Wedbush rating of Hovnanian Enterprises (NYSE:HOV) on 12/16/2024 |
SLDB Solid Biosciences | $5.58
-3.5% | 12/12/2024 | Upgraded by | Wedbush | Analyst L. Chico | Strong-Buy | | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/12/2024 |
RH RH | $346.93
+2.0% | 12/13/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $430.00 -> $500.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 12/13/2024 |
SLDB Solid Biosciences | $5.58
-3.5% | 12/13/2024 | Initiated by | Wedbush | - | Outperform | $16.00 | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/13/2024 |
PZZA Papa Johns International | $48.73
+2.1% | 12/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 12/13/2024 |
ITOS iTeos Therapeutics | $7.34
-0.9% | 12/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 12/12/2024 |
TTD Trade Desk | $74.20
+3.0% | 12/12/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/12/2024 |
LEN Lennar | $119.79
-0.7% | 12/12/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/12/2024 |
LOW Lowe's Companies | $236.66
-1.1% | 12/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $250.00 -> $250.00 | N/A | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
ANAB AnaptysBio | $17.20
-7.5% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 -> $40.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 12/11/2024 |
DBD Diebold Nixdorf | $43.28
-2.6% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 -> $60.00 | N/A | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 12/11/2024 |
ASO Academy Sports and Outdoors | $50.57
-0.5% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 | N/A | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/11/2024 |
TOL Toll Brothers | $110.58
-0.8% | 12/11/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/11/2024 |
VIRC Virco Mfg. | $10.43
-1.8% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 -> $17.00 | N/A | View details for Wedbush rating of Virco Mfg. (NASDAQ:VIRC) on 12/10/2024 |
CMRX Chimerix | $4.76
-7.6% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 12/10/2024 |
TCRX TScan Therapeutics | $2.13
-1.8% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 -> $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/10/2024 |
STRO Sutro Biopharma | $1.71
-3.4% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | N/A | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 12/10/2024 |
CXW CoreCivic | $18.26
+1.3% | 12/10/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $19.00 -> $30.00 | N/A | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 12/10/2024 |
TTWO Take-Two Interactive Software | $212.02
+0.2% | 12/9/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 12/9/2024 |
VOR Vor Biopharma | $1.32
-3.6% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 12/9/2024 |
IRON Disc Medicine | $54.64
+0.2% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 12/9/2024 |
BEAM Beam Therapeutics | $30.79
+1.2% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | N/A | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 12/9/2024 |
EBAY eBay | $69.99
+0.9% | 12/9/2024 | Initiated by | Wedbush | Analyst S. Devitt | Neutral | $70.00 | N/A | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 12/9/2024 |
WOOF Petco Health and Wellness | $2.90
-0.3% | 12/6/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.50 -> $6.00 | N/A | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 12/6/2024 |
GME GameStop | $25.00
-5.4% | 12/6/2024 | Reiterated by | Wedbush | - | Underperform | $10.00 | N/A | View details for Wedbush rating of GameStop (NYSE:GME) on 12/6/2024 |
ROKU Roku | $91.24
+2.7% | 12/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 -> $100.00 | N/A | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 12/6/2024 |
ARE Alexandria Real Estate Equities | $97.16
+1.7% | 12/6/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $120.00 -> $110.00 | N/A | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 12/6/2024 |
CHWY Chewy | $34.42
-2.0% | 12/5/2024 | Reiterated by | Wedbush | - | Outperform | $35.00 -> $39.00 | N/A | View details for Wedbush rating of Chewy (NYSE:CHWY) on 12/5/2024 |
VTR Ventas | $67.81
+2.6% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/3/2024 |
ARGX argenx | $626.13
-2.8% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $655.00 | N/A | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 12/3/2024 |
CVCO Cavco Industries | $518.32
-0.5% | 12/3/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $480.00 -> $480.00 | N/A | View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 12/3/2024 |
TOL Toll Brothers | $110.58
-0.8% | 12/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/2/2024 |
NVCR NovoCure | $21.24
-3.8% | 12/2/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral | $24.00 -> $29.00 | N/A | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 12/2/2024 |
RVMD Revolution Medicines | $41.23
-0.3% | 12/2/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 -> $70.00 | N/A | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 12/2/2024 |
APGE Apogee Therapeutics | $33.37
-3.4% | 12/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $87.00 -> $90.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 12/2/2024 |
UPST Upstart | $70.50
-1.8% | 12/2/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $60.00 -> $75.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 12/2/2024 |
WDC Western Digital | $49.02
-4.9% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 | N/A | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 11/29/2024 |
AAPL Apple | $247.10
+0.6% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 -> $300.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/29/2024 |
PASG Passage Bio | $0.52
-1.3% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $3.00 -> $4.00 | N/A | View details for Wedbush rating of Passage Bio (NASDAQ:PASG) on 11/29/2024 |
VYGR Voyager Therapeutics | $4.10
-2.8% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $7.00 -> $11.00 | N/A | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 11/29/2024 |
DKS DICK'S Sporting Goods | $220.11
-2.0% | 11/27/2024 | Reiterated by | Wedbush | - | Neutral | $250.00 -> $215.00 | N/A | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/27/2024 |
IMAX IMAX | $26.24
+0.8% | 11/27/2024 | Reiterated by | Wedbush | - | Outperform | | N/A | View details for Wedbush rating of IMAX (NYSE:IMAX) on 11/27/2024 |
SRRK Scholar Rock | $37.16
-1.4% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $40.00 -> $47.00 | N/A | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/25/2024 |
PLTR Palantir Technologies | $90.68
-10.5% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $57.00 -> $75.00 | N/A | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 11/25/2024 |
CRM Salesforce | $308.27
-0.5% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $325.00 -> $375.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/25/2024 |
SNOW Snowflake | $170.78
-4.0% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $190.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/25/2024 |
ESTC Elastic | $104.92
-1.4% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $135.00 | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 11/25/2024 |
NTAP NetApp | $123.50
-0.8% | 11/22/2024 | Reiterated by | Wedbush | - | Neutral | $120.00 | N/A | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/22/2024 |
